U.S. flag

An official website of the United States government

NM_000540.3(RYR1):c.14257G>A (p.Ala4753Thr) AND RYR1-related disorder

Germline classification:
Likely benign (2 submissions)
Last evaluated:
Aug 18, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001465780.8

Allele description [Variation Report for NM_000540.3(RYR1):c.14257G>A (p.Ala4753Thr)]

NM_000540.3(RYR1):c.14257G>A (p.Ala4753Thr)

Gene:
RYR1:ryanodine receptor 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19q13.2
Genomic location:
Preferred name:
NM_000540.3(RYR1):c.14257G>A (p.Ala4753Thr)
HGVS:
  • NC_000019.10:g.38578002G>A
  • NG_008866.1:g.149303G>A
  • NM_000540.3:c.14257G>AMANE SELECT
  • NM_001042723.2:c.14242G>A
  • NP_000531.2:p.Ala4753Thr
  • NP_000531.2:p.Ala4753Thr
  • NP_001036188.1:p.Ala4748Thr
  • LRG_766t1:c.14257G>A
  • LRG_766:g.149303G>A
  • LRG_766p1:p.Ala4753Thr
  • NC_000019.9:g.39068642G>A
  • NM_000540.2:c.14257G>A
Protein change:
A4748T
Links:
dbSNP: rs138156449
NCBI 1000 Genomes Browser:
rs138156449
Molecular consequence:
  • NM_000540.3:c.14257G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001042723.2:c.14242G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
RYR1-related disorder
Synonyms:
RYR1-Related Disorders; RYR1-related condition
Identifiers:
MedGen: CN239331

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000852399PreventionGenetics, part of Exact Sciences
no assertion criteria provided
Likely benign
(Jun 27, 2022)
germlineclinical testing

SCV001669775Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely benign
(Aug 18, 2021)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From PreventionGenetics, part of Exact Sciences, SCV000852399.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001669775.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 10, 2024